Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma
Greuter, MJE, Eertink, JJ, Jongeneel, G, Dührsen, U, Hüttmann, A, Schmitz, C, Lugtenburg, PJ, Barrington, SF, Mikhaeel, NG, Ceriani, L, Zucca, E, Carr, R, Györke, T, Burggraaff, CN, de Vet, HCW, Hoekstra, OS, Zijlstra, JM, Coupé, VMH
Published in Clinical lymphoma, myeloma and leukemia (01.06.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2022)
Get full text
Journal Article
FDG‐PET as a Biomarker of Response in DLBCL: the HOVON 84 Study Experience
Burggraaff, C.N., Vet, H.C., Hoekstra, O.S., Arens, A.I., Keizer, B., Holt, B., Lugtenburg, P.J., Zijlstra, J.M.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article